Cite
Puiggros A, Collado R, Calasanz MJ, et al. Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of . Oncotarget. 2017;8(33):54297-54303doi: 10.18632/oncotarget.17350.
Puiggros, A., Collado, R., Calasanz, M. J., Ortega, M., Ruiz-Xivillé, N., Rivas-Delgado, A., Luño, E., González, T., Navarro, B., García-Malo, M., Valiente, A., Hernández, J. �. �., Ardanaz, M. T., Piñan, M. �. �., Blanco, M. L., Hernández-Sánchez, M., Batlle-López, A., Salgado, R., Salido, M., Ferrer, A., Abrisqueta, P., Gimeno, E., Abella, E., Ferrá, C., Terol, M. J., Ortuño, F., Costa, D., Moreno, C., Carbonell, F., Bosch, F., Delgado, J., & Espinet, B. (2017). Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of . Oncotarget, 8(33), 54297-54303. https://doi.org/10.18632/oncotarget.17350
Puiggros, Anna, et al. "Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of ." Oncotarget vol. 8,33 (2017): 54297-54303. doi: https://doi.org/10.18632/oncotarget.17350
Puiggros A, Collado R, Calasanz MJ, Ortega M, Ruiz-Xivillé N, Rivas-Delgado A, Luño E, González T, Navarro B, García-Malo M, Valiente A, Hernández JÁ, Ardanaz MT, Piñan MÁ, Blanco ML, Hernández-Sánchez M, Batlle-López A, Salgado R, Salido M, Ferrer A, Abrisqueta P, Gimeno E, Abella E, Ferrá C, Terol MJ, Ortuño F, Costa D, Moreno C, Carbonell F, Bosch F, Delgado J, Espinet B. Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of . Oncotarget. 2017 Apr 21;8(33):54297-54303. doi: 10.18632/oncotarget.17350. eCollection 2017 Aug 15. PMID: 28903342; PMCID: PMC5589581.
Copy
Download .nbib